Eagle Eye Valuation, Comparative Analysis And 10-Year Financial Projections Analyzed
IPVM has obtained Eagle Eye's corporation documents, allowing us to analyze the valuation Eagle Eye investors have obtained, including most recently $100 million fundraising from Secom.
** **** ******** ******, ** ***** and ******* ***** ***'* ******** ******** stock ***********:
- *********** *** ****** ********* *** ***** Eye
- ********* *** ***** **** *** ** VC *********, ** ****, ** ***** ******** *************** ** ****.
- ********* ** ** *** ********** ** Ava, ********, *****, *********, *******, *** Verkada
- ********* **** *********** ** ***** ***'* revenue *** ******* **** *** **** decade, ******* *** ***** *** ********** Eagle *** **** **** ** ******, relative ** ******* ***********, ** ******* its *********
*********
** ******** ~$*** ******* ***-***** ********* for ***** *** **** *** **** recent ***** ***** ******* ***'* ******** ***** *********** **** Delaware, ***** ********* ~*** ******* ********* shares **** *** ****** ***** ***** of ~$*.** (*.*., *** ******* * $1.80 = ~$*** *******), *********** ***** from ***** ***********:
*****'* ****** ******* *** ~**% ** all ****** ********* ******, ************* *******'* $*** ******* ********** ** ***** Eye(*.*., $*** ******* * .** = ~$100 *******).
******* ****,***** ******, ********* **** $*.** *******, *** ** ******* ***** ******** is *** **** ***** ** *** explanation ***** *** ******** *********.
***** *** ******** ******** ** *******, but ** *** ********* **** ** the ******* *****.
Funding *** ******
** ****, ***** *** *** ****** ~$181.5 ******* ** ******* ****** ******** rounds,**** $*** ******* ** *** **** from ***** (****** *-*).
***** ***'* ****** ***** ******** *** ~20% ** ****** ********* ***** ** ~7% ** *** *****. ***** *** F-2 ***** ***** ~*** ******* ****** preferred ******, ********** *** ~$*** *******, though***** ******** ~$*** ******* ** ***** Eye, *** ******* ** ***** ****** ownership *** *** ********* *** ************ could ** ******** *****.
****** *** ******, *** ***** ***** for ***** *** ****** *** ************* increased, **** ***** *** ******** *** issue ***** **** *** ****** * round ** ****.
Accel **. ***** *******
******* *** *** ****** ****** **** a **** *** * **** ***** (******* ******.***** ****) *** *** *********** ****** ******** far ****** ** *******, ***** ******** at ******* ****** *** ********* **** Accel *** (~$*** ******* ****** ~$*** million).
** ******* ***** **** * *********** premium *** **** *****, ***** ***** market ********** *** *****'* ******** ** a ******* ******** ********** **** ***** need ** *** * ****** ***** to ******* **** ***** ******* ****** venture ***********.
***********
*** ***** ***** ******** ******* *** valuation *** * ********* ** ***** management **** **** ******** ****** ******* or **** ******** ** *** **** decade. *** ***** ** ***** ******** have ******* ********* ************* *** *** more ****** *****:
** ******** ***** ***'* ********* *** product ** ***, ********, *****, *********, OpenEye, *** *******, *** ******** *** positioning ** ***** *** **. *** competitors.
***:******** ******** *** ** **** *** ~$400 *******, ********* *** ***** ************ ******** to *** *****. **** ********* ***'* revenue ** ** ** *** *** tens ** ******** ** *** **** of *** ***********, **** * ***-*** p/s *****. ***'* ************ ******* ***** better *********** **** ***** ***'* (****** ******* ******,***** *** ****** ** ***** ******* Tested), *** *** * ***** *** stronger ********* ******** (****** *** *** ***** ********* ******,***** *** ******** "***** ***** ******" Tested), *** *** ***** ****** ****** than ***** *** ******'* ***** ********.
************ ************* *** ***** *** ******** brand, **** ******* ***'* ******* ** increase *******, *** ** **** **** to ***** *** ******* **** ******** paid.
********:******** ******** ******** ** **** *** ~$1 *******, **** ******** ******** ~$*** ******* in ******* ** *** ****. ******** is * ****** *********** ** ********, with *** ******* ********* **** ***** surveillance ******* ********'* ***-**-*** ******** *** the ****** ******** ***** ************ ***** now **** $*.* ******* ********.
******** ** ***** ***, ******** ****** stronger ******* (*********** *** ******** ******* ******)*** ********* *********** (********* ********* ******** **** - ** Manufacturers, ** *********).
***********:**** ******** ***** ** **** *** ~$150 ******* ** ****, **** ***** ********* ~$** ******* in ******* ** ****. ** ******** Exacq *** ********* $*** ******* ** annual *******. **********'* ************ ** *********** *** ************* ****/*** ***********, ***** *** **** a **** **** *********** *** ****/*** but *** ******* / ******** *********** positioning *** ****** ******* ** *** past ******.
*********:***** ******** ********* ** **** *** never ********* *** ** ******* ~$*** million, **** ********* ********* ~$** ******* in ******* ** ****. ***** ********* had ******** ******** (************ ******* **, ******* ****,********* **** ** ****** ******** ** 70%,********* ******** *** ***** **** ** Months), ********* ******** * ~$*** ******* in ******* ** ****. *******, *** net ****** ******* **** ~*% *** ****, ********** **** ~**%.
*******:*****.*** ******** ******* ** **** *** $72 *******, *** ** ********* *******'* ******* in *** *** **** ** ******** at *** ****. ***** *** ***********,******* ******** *** ********,******* ****** **** ***** *** ******'* ***** ********. *******'* ***** *********** ***** ******** an *********** *** *****.*** ** ******** a ***** ******* ******, ******* * strong ***** **** *** ***********. ** its ******* *********, ***** *** **** not ******* ******* ***** *** *********.
Verkada: While Verkada has not been acquired or IPO'd, it has ****** ~$*** ******* ** **** **** a ~$*.* ******* *********. ******* ****** ** ***-**-*** ******** and ******* ********-**-*-************, ***** ** ***** *** ********* with *** ********. ******** ** ***** Eye's **** ********, ******* ******* *****-**** license ********* **** *** ********* **** its *******-**-*-******* *****. ***** ******* ****** lower **** ***** *** ******'* ***** ********, ******* ****** * **** ***** of ******** ********* ******** *********, ******** it ** ******** *** **** ******* than ***** ***.
Future ******* ***********
**** ***** ******* ***** ***'* **** revenue **** ** ** *** ***** of $* *******. *****, ** ******* three *********. *** ***** ** ******** zero ****** ** * ****** (*.*., flat), ** ******** ***** *** **** need ** ******** $***+ *******, ***** for ** ** ******** * **% CAGR, ***** ***'* ******* **** **** to ** **** $*** *******:
*** ******** **** ******* ***** *** will **** **% *** ******* *** that, ** * ****** ******* ** 2033, ** **** ** ****** ** 15 ***** *** ********. **% *** margins *** ***** **** *****'* ***** video ************ ********* ********* ******* (****, e.g., ************, *** **** ~**%), *** we ****** **** ********** *** ** more **********. *** */* ******* *** company ** ****** *** *** *** growth ** *** *****.
** ******, **** ****** *********** *** into *** ******, *********** *** **** out *****, *** ** ********* ************* to ****** ***** ******* *** ***** own *** ** ***********.
********, *****, ** ******* **** ******* CAGR ***** *** ***** **** ** maintain *** * ****** ** ***** those ******* ******:
*** *** **** *** *****, * ~30% ****** ******* ****** **** ****** be **** *** ***** *** ** achieve , *** ** *** ***** numbers, ** **** ** ********** *** a ******.
** ****** ***** ***'* **** ******* was ~$** *******. ** ** *** significantly *** ** ****, *** ******** would *************** ** *********. ***** *** is ***** ********** ** *** ****** revenue *******.
Eagle *** $* ******* ****** ******* ***********
** ** ******** *** ***** *** to ***** * ******* ******* ** annual ******* ** * ******, *** it **** ******* ***** *** ** perform (***********) ** *** **** ********** video ********** ******* **** (** *** it ** ********* ****** **** ****** its *** *******, ***** ** *** something ** *** **** ** ****, it ******** ******).
***** **** * *********** *******, ** our ********, *** *** ********** ** Eagle ***, ***** ******** * ****** cash ***** *** ***** *** ** expand *** **** ******* ********* *********** to ******* ** **** ****.